Skip to content
Search

Latest Stories

NHS England announces new executive team to lead transformation

NHS England restructures leadership with new executive team

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025.

Getty Images

Sir James Mackey will be leading NHS England’s transition into the Department of Health and Social Care (DHSC), along with the incoming team.

He will officially take up the role as the new chief executive officer of NHS England on 1 April 2025, replacing Amanda Pritchard, who is stepping down at the end of this month.


On Monday, NHSE announced the NHS Transformation Executive Team, which will replace the current executive group.

The organisation said that the new team, composed of leaders from within the NHS and seconded roles, has been appointed following discussions with the health secretary Wes Streeting, DHSC officials, incoming Chair Dr Penny Dash, and the NHS England Board.

As part of the restructuring, the roles of chief operating officer and chief delivery officer have been removed.

Instead, the new structure introduces two co-medical directors, and new positions such as a financial reset and accountability director and elective care, cancer and diagnostics director.

NHS Transformation Executive Team

  • Sir James Mackey – chief executive officer, responsible for overall accountability and leadership of the organisation. Temporarily, he will also oversee HR, OD and corporate operations; privacy, transparency and trust; legal; corporate governance; performance and delivery unit; inquiries; mental health, learning disability and autism.
  • David Probert - Deputy CEO
  • Meghana Pandit- Co-Medical Director – Secondary Care
  • Claire Fuller - Co-Medical Director – Primary Care
  • Duncan Burton- Chief Nursing Officer
  • Elizabeth O’Mahony - Chief Financial Officer
  • Glen Burley - Financial Reset Director and Accountability Director
  • Mark Cubbon - Elective Care, Cancer and Diagnostics Director
  • Vin Diwakar- Clinical Transformation Director
  • Sarah-Jane Marsh - Urgent and Emergency Care Director
  • Dr. Amanda Doyle- National Director of Primary Care and Community Services

Additionally, seven regional directors have been appointed:

  • Anne Eden – South East
  • Claire Panniker – East
  • Dale Bywater – Midlands
  • Fiona Edwards – North East and Yorkshire
  • Louise Shepherd – North West
  • Caroline Clarke – London
  • Sue Doheny (acting) – South West

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025 to support ongoing business priorities, statutory functions, and day-to-day operations.

Glen Burley, Mark Cubbon and David Probert will continue their current trust roles alongside their new roles within the Transformation Executive Team.

Professor Stephen Powis will remain in his role as national medical director until early July, working closely with Meghana Pandit and Claire Fuller to finalise arrangements for the medical directorate.

Regional Directors will report directly to Sir Mackey, as will Navina Evans (chief workforce, training and education officer) and Chris Hopson (chief strategy officer).

A new substantive chief digital officer is expected to be recruited soon.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less